ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the (Q85395509)
Jump to navigation
Jump to search
scientific article published on 01 November 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the |
scientific article published on 01 November 2012 |
Statements
ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design (English)
Patrick W Serruys
Yoshinobu Onuma
Hector M Garcia-Garcia
Roberto Diletti
Bernard Chevalier
Richard Rapoza
Susan Veldhof
Cecile Dorange
Karine Miquel-Hebert
Krishnankutty Sudhir
1 November 2012